What other peptides are people stacking with their GLP-1 — my results so far

julia.endo said:

Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

ZaraB_AL said:

The mechanism is more central than most summaries suggest.

Saving this. It is the first explanation that did not require me to already understand it. Taking it to my next appointment.

julia.endo said:

Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Carry on.